ArticleTrials2019

A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trial.

Judy Martina Bradley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.